Article
Characterization of an EG.5.1 clinical isolate <i>in vitro</i> and <i>in vivo</i>
2023-09-01
Abstract excerpt
EG.5.1 is a subvariant of the SARS-CoV-2 Omicron XBB variant that is rapidly increasing in prevalence worldwide. EG.5.1 has additional substitutions in its spike protein (namely, Q52H and F456L) compared with XBB.1.5. However, the pathogenicity, transmissibility, and immune evasion properties of clinical isolates of EG.5.1 are largely unknown. In this study, we used wild-type Syrian hamsters to investigate the rep...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d422acd4-ceb8-589a-bfa5-f9cb6ddb14b0
- DOI
- 10.1101/2023.08.31.555819
